Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (OnlineFirst PDF)
Right arrow All Versions of this Article:
0009922807306169v1
47/2/148    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Heneghan, A.
Right arrow Articles by Horwitz, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heneghan, A.
Right arrow Articles by Horwitz, S. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Child Mental Health
*Children's Health
*Teen Mental Health
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Use of Selective Serotonin Reuptake Inhibitors by Pediatricians:: Comparing Attitudes of Primary Care Pediatricians and Child and Adolescent Psychiatrists

Amy Heneghan*, Andrew S. Garner, MD, PhD, Amy Storfer-Isser, MS, Karl Kortepeter, MBA, MS, Ruth E. K. Stein, MD, and Sarah McCue Horwitz, PhD

* To whom correspondence should be addressed. E-mail: axh65{at}case.edu.


   Abstract
To compare attitudes regarding a pediatrician’s role in prescribing selective serotonin reuptake inhibitors for children and adolescents, surveys were mailed to 338 primary care pediatricians and 75 child and adolescent psychiatrists; half responded. Child and adolescent psy chiatrists were significantly more likely than primary care pediatricians to agree that selective serotonin reuptake inhibitors are safe and effective when used for children and adolescents. Primary care pediatricians were significantly more likely than child and adolescent psychiatrists to agree that black box warnings have changed their prescribing practices. Both had similar beliefs about whether antidepressants should be prescribed only by psychiatrists and whether pediatricians should initiate selective serotonin reuptake inhibitor therapy, without or after consulting a psychiatrist. These data suggest that among child and adolescent psychiatrists and primary care pediatricians, agreement about the pediatrician’s role in using selective serotonin reuptake inhibitors therapy is lacking. Strategies that enhance communication and endorse support for defined roles of primary care pediatricians and child and adolescent psychiatrists will ensure that children with mental health needs are treated safely and appropriately.

First published on September 14, 2007, doi:10.1177/0009922807306169

Clinical Pediatrics 2008;47:148.

A more recent version of this article appeared on March 1, 2008


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Psychiatr. Serv.Home page
B. D. Fulton, R. M. Scheffler, S. P. Hinshaw, P. Levine, S. Stone, T. T. Brown, and S. Modrek
National Variation of ADHD Diagnostic Prevalence and Medication Use: Health Care Providers and Education Policies
Psychiatr Serv, August 1, 2009; 60(8): 1075 - 1083.
[Abstract] [Full Text] [PDF]